Comparison of short-term clinical efficacy and safety of robotic and laparoscopic distal pancreatectomy
10.3760/cma.j.cn113884-20240504-00132
- VernacularTitle:达芬奇机器人与腹腔镜胰体尾切除术近期临床疗效和安全性对比研究
- Author:
Jun YANG
1
;
Qigui XIAO
;
Man ZHANG
;
Zheng WU
;
Zheng WANG
;
Wei LI
Author Information
1. 西安交通大学第一附属医院肝胆外科 西安交通大学胰腺疾病诊疗中心，西安 710061
- Keywords:
Robotic surgical procedures;
Pancreatic neoplasms;
Laparoscopes;
Surgical procedures, operative;
Efficacy
- From:
Chinese Journal of Hepatobiliary Surgery
2024;30(5):330-334
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To compare the short-term clinical efficacy and safety of Da Vinci robot and laparoscopic pancreatectomy.Methods:The data of patients with pancreatic occupying lesions who underwent distal pancreatectomy in Department of Hepatobiliary Surgery, First Affiliated Hospital of Xi′an Jiaotong University from September 2021 to January 2024 were retrospectively analyzed. A total of 60 patients were enrolled, including 20 males and 40 females, aged (52.0±14.8) years. According to different operation methods, 60 patients were divided into robotic group ( n=30, Da Vinci robot-assisted pancreatectomy) and laparoscopic group ( n=30, laparoscopic pancreatectomy). The conversion of laparotomy, operation time, intraoperative blood loss, splenic preservation, postoperative hospital stay, postoperative fasting time, reoperation rate within 30 days after surgery, readmission rate within 90 days after surgery, and postoperative complications such as abdominal hemorrhage, abdominal infection and pancreatic fistula were compared between the two groups. Results:There was no conversion to laparotomy in the laparoscopic group, and 1 case (3.3%) in the robotic group. There were no significant differences in conversion to laparotomy rate, operation time, intraoperative blood loss, postoperative hospital stay, reoperation rate within 30 days after surgery, and readmission rate within 90 days after surgery between the two groups (all P>0.05). The spleen preservation rate of the robotic group was 53.3% (16/30), and the postoperative fasting time was 1.0(1.0, 2.0) d, which was better than that of the laparoscopic group 23.3%(7/30), 2.0(2.0, 3.0) d, with statistical significance ( χ2=5.71, Z=4.04, P=0.017, P<0.001). Postoperative abdominal infection occurred in 6 cases (20.0%), grade B or C pancreatic fistula in 7 cases (23.3%), no abdominal hemorrhage in the laparoscopic group, postoperative abdominal hemorrhage in 3 cases (10.0%), abdominal infection in 4 cases (13.3%), and grade B or C pancreatic fistula in 8 cases (26.7%) in the robotic group. There was no significant difference in the incidence of postoperative abdominal hemorrhage, abdominal infection and grade B or C pancreatic fistula between the two groups (all P>0.05). Conclusion:Da Vinci robotic pancreatectomy is safe and feasible, and the success rate of spleen preservation is better than laparoscopic pancreatectomy.
